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Abstract
Emerging infectious diseases are rising globally and understanding host-pathogen in-
teractions during the initial stages of disease emergence is essential for assessing po-
tential evolutionary dynamics and designing novel management strategies. Tasmanian 
devils (Sarcophilus harrisii) are endangered due to a transmissible cancer—devil facial 
tumour disease (DFTD)—that since its emergence in the 1990s, has affected most 
populations throughout Tasmania. Recent studies suggest that devils are adapting 
to the DFTD epidemic and that disease-induced extinction is unlikely. However, in 
2014, a second and independently evolved transmissible cancer—devil facial tumour 
2 (DFT2)—was discovered at the d’Entrecasteaux peninsula, in south-east Tasmania, 
suggesting that the species is prone to transmissible cancers. To date, there is little 
information about the distribution, epidemiology and effects of DFT2 and its inter-
action with DFTD. Here, we use data from monitoring surveys and roadkills found 
     |  1773JAMES Et Al.
1  | INTRODUC TION
Emerging infectious diseases are becoming a critical concern 
for wildlife conservation, livestock and public health (Daszak, 
Cunningham, & Hyatt, 2000; Johnson, Roode, & Fenton, 2015; 
Jones et al., 2008). There has been an increasing interest among 
ecologists, evolutionary and conservation biologists in understand-
ing and managing infectious diseases (Galvani, 2003; Johnson et al., 
2015). This is because the causes and extent of local adaptations 
in natural host-pathogen systems are a central aspect of adaptive 
evolution and species survival. Species suffering population declines 
from factors such as habitat loss or fragmentation are often more 
susceptible to emerging diseases, because of decreased genetic di-
versity (Altizer, Harvell, & Friedle, 2003; Ujvari et al., 2018). Initial 
data collection at the early stages of the epidemic onset is critical for 
understanding selective processes between host and pathogens and 
for implementing control interventions, with predictive models aid-
ing in identifying the best management options for the disease stage 
(Langwig et al., 2015). For example, pathogen presence in isolated 
areas may allow for selective culling, aimed at reducing infection 
rates (Jennelle et al., 2014), or whole-population eradication (stamp-
ing out) aimed at eliminating disease from specific geographic areas 
(Scudamore & Harris, 2002). However, the identification, capture 
and removal of a large proportion of infected individuals in wildlife 
diseases is in many cases not possible due to logistic constraints, 
particularly at large spatial scales (Langwig et al., 2015; Wobeser, 
2002). A trial of selective culling to eradicate a transmissible cancer 
on the Forestier peninsula in south-east Tasmania was unsuccess-
ful (Lachish, McCallum, Mann, Pukk, & Jones, 2010), and modelling 
suggested that no feasible rate of culling infected animals would be 
successful in eradicating the disease (Beeton & McCallum, 2011).
Tasmanian devils, Sarcophilus harrisii, are threatened by a clonal 
transmissible cancer cell line–devil facial tumour disease (DFTD) 
(Hawkins et al., 2006; Pearse & Swift, 2006). The disease emerged 
more than two decades ago and has caused extensive population de-
clines throughout 80% of the species distributional range (Lazenby 
et al., 2018; McCallum et al., 2009). Transmission occurs via direct 
inoculation of live tumour cells when devils bite each other (Hamede, 
McCallum, & Jones, 2013; Pearse & Swift, 2006). DFTD is able to 
evade host immune detection via epigenetic down-regulation of 
major histocompatibility complex (MHC) gene expression in tumour 
cells (Siddle et al., 2013). The patterns of spatial spread observed 
in the first 10 years of DFTD emergence were consistent with an 
infectious disease from a single origin, with around 60% of the geo-
graphic range of devils in Tasmania confirmed to have DFTD by early 
2007 (McCallum et al., 2007). DFTD continued to move across the 
landscape (Bode, Hawkins, Rout, & Wintle, 2009), but spatial spread 
was variable, with a rate of approximately 25 km per year southward 
through continuous forested habitat, compared to approximately 
17 km per year southwest through heterogeneous habitat (McCallum 
et al., 2007). This suggests that landscape heterogeneity may influ-
ence disease spread; for example, cool temperate rainforests and 
highlands, both suboptimal habitat for Tasmanian devils, may act as 
environmental barriers (Storfer et al., 2017). At a more local scale, 
DFTD spread into the 160 km2 Freycinet peninsula on the east coast 
of Tasmania at a rate of only 7 km per year (McCallum et al., 2007), 
potentially slowed by geographic barriers such as mountains with 
less suitable habitat.
The epidemiology and ecology of DFTD have been consis-
tent in all affected populations for which medium to long-term 
(5 to >10 years) data are available. Given that the disease is 
transmitted by biting and most biting occurs during the mating 
within and adjacent to the d’Entrecasteaux peninsula to determine the distribution of 
both cancers and to compare their epidemiological patterns. Since 2012, a total of 51 
DFTD tumours have been confirmed among 26 individuals inside the peninsula and 
its surroundings, while 40 DFT2 tumours have been confirmed among 23 individuals, 
and two individuals co-infected with both tumours. All devils with DFT2 were found 
within the d’Entrecasteaux peninsula, suggesting that this new transmissible cancer 
is geographically confined to this area. We found significant differences in tumour 
bodily location in DFTD and DFT2, with non-facial tumours more commonly found 
in DFT2. There was a significant sex bias in DFT2, with most cases reported in males, 
suggesting that since DFT2 originated from a male host, females might be less suscep-
tible to this cancer. We discuss the implications of our results for understanding the 
epidemiological and evolutionary interactions of these two contemporary transmis-
sible cancers and evaluating the effectiveness of potential management strategies.
K E Y W O R D S
disease ecology, emerging infectious disease, epidemiology, Tasmanian devil facial tumour 
disease, transmissible cancer
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season (Hamede, McCallum, & Jones, 2008; Hamede et al., 2013; 
Hamilton et al., 2019), DFTD transmission has been described as 
frequency-dependent and affects mostly sexually mature adult 
devils (McCallum et al., 2009). The low DFTD prevalence in sub-
adults might be attributed to the low number of bite wounds in this 
demographic group, (Hamede et al., 2013), an apparent extended 
latent period of DFTD (McCallum et al., 2009) and/or differences 
in immune function between subadults and adults (Cheng et al., 
2017; Ujvari, Hamede, et al., 2016). There has been no evidence 
of differences in DFTD prevalence between males and females 
across multiple sites at different stages of the epidemic (Hamede 
et al., 2012; Kwon et al., 2018; Lachish, Jones, & McCallum, 
2007; McCallum et al., 2009) indicating that males and females 
are equally susceptible to contract the disease, most likely during 
mating interactions. There are two ways in which DFTD trans-
mission has been postulated, from the biter animal to the bitten 
(inoculation of tumour cells from infected to susceptible) or from 
the bitten animal to the biter (susceptible animal biting into the 
tumour of an infected individual). Hamede et al. (2013) found that 
most tumours were inside the oral cavity, suggesting that trans-
mission occurs mostly from the bitten to the biter when the most 
aggressive animals deliver bites to infected subordinated individ-
uals. Although most bite wounds have been recorded on the head, 
they have also been found in other parts of the body such as the 
rump, back, limbs and tail (Hamede et al., 2008, 2013; Hamilton 
et al., 2019; Pemberton & Renouf, 1993). However, almost invari-
ably tumours have been recorded on the head and there are no 
records in the published literature of primary tumours occurring 
at any other location than the head (Hamede et al., 2013; Loh et 
al., 2006).
In 2014, a second clonal transmissible cancer cell line was dis-
covered in Tasmanian devils, devil facial tumour 2 (DFT2) (Pye, 
Pemberton, et al., 2016). Although genetically distinct from DFTD, this 
newly emerged and independently evolved transmissible cancer pres-
ents similar morphological symptoms to DFTD, (Pye, Pemberton, et 
al., 2016). Cytogenetically, DFT2 carries a Y chromosome contrasting 
with the female origin of DFTD (Deakin et al., 2012; Murchison et al., 
2012; Pearse & Swift, 2006; Pye, Pemberton, et al., 2016). Although 
sample sizes were very low, Kwon et al. (2018) reported a significant 
effect of sex in DFT2 prevalence. Of the 11 cases of DFT2 detected by 
Kwon et al. (2018), nine were males, suggesting that females could be 
less susceptible to this cancer. DFT2 was first reported in 2014 within 
the d’Entrecasteaux peninsula in south-east Tasmania, whereas DFTD 
was first reported in the same peninsula in 2012 (Pye, Pemberton, et 
al., 2016). So far, there is limited information about the epidemiology 
and aetiology of DFT2 (but see Stammnitz et al., 2018) and the addi-
tional conservation threat it may pose for the already endangered spe-
cies. In contrast to DFTD, DFT2 cells express MHC class I molecules, 
although the most highly expressed MHC alleles are shared with hosts 
carrying tumours (Caldwell et al., 2018). Co-infection with DFTD and 
DFT2 has been reported in the same host (Kwon et al., 2018); thus, 
competition and selective processes between these two transmissi-
ble tumours are expected both at individual and population levels. A 
better knowledge of the interaction between these two transmissible 
cancers might allow the evaluation of potential epidemiological and 
evolutionary dynamics between devils, DFTD and DFT2, and assess 
whether management interventions are required.
Here, we determine the current distribution of DFTD and DFT2 
within south-east Tasmania, compare the population demography of 
the two cancers and examine the bodily location of tumours within 
F I G U R E  1   Map of Tasmania and the d’Entrecasteaux peninsula in south eastern Tasmania showing the five study sites where standard 
live trapping was undertaken and the location of all diseased animals. The arrow indicates the first detected case of DFT2 in 2014
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individual hosts. We discuss the implications of our study for eval-
uating the epidemiological and evolutionary interactions of the two 
transmissible cancers and discuss the effectiveness of potential 
management and disease control strategies.
2  | MATERIAL S AND METHODS
2.1 | Study area, trapping methods and data 
collection
Tasmanian devils were trapped at five different sites within and ad-
jacent to the d’Entrecasteaux peninsula (43°6′S, 147°9′E), in south-
east Tasmania (Figure 1). The peninsula is located between the 
d’Entrecasteaux channel to the east, the Huon River to the west and 
the Huon Highway to the north. The area is approximately 550 km2 
and predominantly consists of wet and dry sclerophyll forests and 
cleared agricultural land situated on rural residential properties along-
side crown land and nature conservation areas. The landscape is topo-
graphically varied with peaks rising to 800 m. A core monitoring area 
(Woodbridge, 43°09′S 147°11′E) at the centre of the peninsula was 
established in 2016, consisting of 40 individual trap locations cov-
ering an area of 25 km2. Traps were monitored for ten consecutive 
nights at monthly intervals during July–December 2016; July, August 
and December 2017; and February, April and May 2018. In addition, 
four adjacent trapping sites (Snug Tiers, 43°02′S, 147°10′E; Longley, 
42°58′S 147°10′E; Lonnavale, 42°56′S, 146°49′E; and Southwood, 
43°04′S 146°50′E) around the core area were sampled in 2011, 2015, 
2016 and 2017 to monitor the presence of DFTD (2011–2018) and 
DFT2 (2014–2018). These sites were sampled with 40–70 traps set 
for five to ten nights. For a full description of trapping protocols at 
each site, Table S1. In all study sites, PVC culvert pipe traps were used 
and all captured individuals were permanently marked by implanting 
a microchip transponder subcutaneously at the nape of the neck. A 
series of standard measures including weight, sex, ageing parameters, 
reproductive status and disease status were collected, as described 
in Hamede et al. (2012). We aged devils using a combination of molar 
eruption, molar wear and canine over eruption (distance from the den-
tine–enamel junction to the gum). This method is considered precise 
for ageing devils up to 3 years old (Jones M., unpublished data); hence, 
we pooled devils of ≥3 years into a single age class. We collected biop-
sies for diagnosis of each individual tumour from devils trapped with 
visual signs of DFTD and DFT2. Tumour biopsies collected from devils 
that were euthanized for welfare reasons (advanced stage of DFTD/
DFT2), and roadkills during 2012–2018 were also used to monitor the 
presence of DFTD and DFT2 (post-2014) in the study area. Data on 
devil age were not available for five individuals, and therefore, these 
individuals were not used for the analysis of tumour type and age 
class. For a full list of tumour samples and metadata, see Table S2.
2.2 | Data analysis and tumour diagnostic test
All tumours were diagnosed as DFTD or DFT2 by using the 
Tasman-PCR genetic diagnostic assay (Kwon et al., 2018) or by 
histopathological examination of tumour biopsies (Pye, Pemberton, 
et al., 2016). The location of each individual tumour was recorded as 
either on the head (including inside the oral cavity) or on the body 
of the diseased animal (any location other than the head). Pearson’s 
chi-square test of independence was used to evaluate differences 
between the location of the tumour and the disease type (DFTD or 
DFT2). Due to the small sample sizes across demographic groups, 
Fisher’s exact tests of independence were used to evaluate differ-
ences between the sex of individuals and disease type, likelihood 
of co-infection, as well as the age of infected devils and disease 
type. All statistical analyses were performed using R (R project for 
Statistical Computing, version 3.4.3). The location of all infected 
devils was recorded and mapped in ArcGIS to map the presence of 
DFTD and DFT2 within and outside the d’Entrecasteaux peninsula.
3  | RESULTS
A total of 350 individual Tasmanian devils (183 males, 163 females, 
one intersex and three individuals with missing data) were examined 
adjacent to and within the d’Entrecasteaux peninsula between 2012 
and 2018. Of these, 26 individuals were diagnosed with DFTD, 23 
with DFT2 and two additional individuals were co-infected with both 
tumours. Of all infected devils, 13 individuals with DFTD and 10 indi-
viduals with DFT2 had more than one tumour, although co-infection 
with DFTD and DFT2 in the same host was found in only two individu-
als (Kwon et al., 2018). This is the expected number of co-occurrences 
if infection by DFTD and DFT2 is independent events (p = 1, Fishers 
exact test), when analysing the entire data set. However, given that 
males are significantly more likely to be infected by DFT2 (see below) 
and that juveniles are rarely observed with tumours, we restricted the 
analysis to adult males. The non-significant results (p = 0.47, Fisher’s 
exact test) support the independent nature of DFTD and DFT2 infec-
tions. Since 2012, a total of 91 tumours have been confirmed in 51 
individuals (51 DFTD and 40 DFT2 tumours) within the region of south 
eastern Tasmania, both adjacent to and within the peninsula (Figure 1). 
DFTD has been detected only 15 km south into the peninsula since it 
was first observed in 2012. Since the discovery of DFT2 in 2014, all 
cases have been confined to the d’Entrecasteaux peninsula (Figure 1).
There was a significant difference in the bodily location of in-
dividual DFTD and DFT2 tumours on the animals, with DFT2 tu-
mours occurring more frequently on the body than DFTD tumours 
(X2 = 7.801, df = 1, p = 0.005, Figure 2a). We found a significant dif-
ference in the sex of the animal and tumour type, with more DFT2 
cases in males (p = 0.0377, Fisher’s exact test) but this was not the 
case for DFTD (p = 0.789, Fisher’s exact test) where males and fe-
males were equally affected (Figure 2b). There was no significant 
difference between the age of infected devils and disease type 
(p = 0.99, Fisher’s exact test, Figure 3) suggesting that disease type 
does not affect the age at which individuals become infected.
For information on the location of animals with DFTD and DFT2 
that were trapped, sampled as roadkill or euthanized and a full de-
scription of devil and tumour data, Table S2.
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4  | DISCUSSION
To date, DFT2 has been only found within the d’Entrecasteaux 
peninsula with all confirmed cases occurring since 2014 present 
in this area. As the peninsula is bounded by water on three sides, 
the Huon River to the west and d’Entrecasteaux Channel to the 
east and south, the only direction for DFT2 to escape its current 
geographic confinement is northward. We acknowledge that a 
larger sampling effort in areas north of the peninsula is necessary 
to firmly conclude that DFT2 has not escaped the confinement 
of the peninsula; therefore, our estimates of current distribution 
should be interpreted with caution. Continual monitoring in areas 
adjacent to the peninsula, particularly north of the Huon Highway 
and west of the Huon River are required to establish potential 
spread of DFT2 beyond its current known distribution. Since it 
was first detected in 2014, DFT2 has been found 12 km north and 
16 km east from its original sampling location in the east central 
part of the peninsula. Although we cannot precisely identify the 
location of the index case of DFT2, the spatial movement at a 
local scale since first detection appears to be similar to the 7 km 
per year rate of movement of DFTD observed on the Freycinet 
peninsula (McCallum et al., 2007). However, at a large spatial 
scale, the DFT2 movement since 2014 is much slower compared 
to DFTD spread throughout continuous suitable habitat from its 
emergence in Tasmania’s north-east in 1996, which was 25 km per 
year (McCallum et al., 2007). Whether this is the result of gradual 
spread from a single focal population or multiple populations re-
mains unknown.
The slow movement of DFT2 across the landscape and relatively 
low infection rates (25 infected individuals detected, from 350 ex-
amined in 4 years, compared with DFTD prevalence of up to 50% 
reported by McCallum et al., 2009) may alternatively be due to inter-
actions and/or competition with DFTD; however, this competition 
might have different modalities. For example, the timing of DFT2 
emergence in an area already affected by DFTD and its subsequent 
population decline could slow the epidemic progress of DFT2. The 
latent period of both cancers is currently unknown, but in DFTD, 
it can be as long as 13 months (Save the Tasmanian devil Program, 
personal communication). Therefore, it is possible that infected indi-
viduals with DFTD had been subsequently infected with DFT2 but 
they may have succumbed to the first infection before developing 
visible DFT2 tumours, or vice versa.
Another plausible explanation is the difference in MHC class 
I expression between both tumours. There is evidence that DFT2 
cells express classical and non-classical MHC alleles, which is likely 
to lessen the immunogenicity of tumour cells and reduce suscepti-
bility infection (Caldwell et al., 2018). However, the expression of 
MHC molecules in DFT2 is not uniform and, given its early stage 
of evolutionary history, is possible that it might be gradually lost, 
facilitating a possibly higher rate of transmission. In DFTD, it has 
been shown that tumour cells lack expression of MHC class I; how-
ever, this is reversible upon treatment with the inflammatory cyto-
kine IFNγ (Siddle et al., 2013). This suggests that during the early 
F I G U R E  2   (a) Number of tumours on diseased Tasmanian devils from DFTD and DFT2 on bodily locations and (b) differences between 
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stages of DFTD evolutionary history, MHC class I could have been 
expressed and subsequently down-regulated, increasing its ability 
to transmit and spread throughout Tasmania. Given that DFTD was 
first detected in 1996 but consistent monitoring did not start until 
2004, it is not possible to determine the MHC class I expression pro-
files of early DFTD lineages or establish whether the transmission 
rate of these lineages was slower than the current tumours. Further 
evaluation of these processes as the DFT2 epidemic unfolds will be 
essential to contrast the epidemiology and evolution of both cancers 
as well as understanding the adaptive potential of malignant cells 
and their hosts.
The effect of multiple tumours on disease-induced mortality 
could result in a temporal reduction of the infectious period and con-
sequently the transmission and spread of both cancers. Devils usu-
ally succumb to DFTD within 12 months after the onset of clinical 
signs as a result of growing tumours that lead to metabolic starva-
tion, organ failure and in some cases metastasis (Hamede et al., 2012; 
Loh et al., 2006). Co-infection with both DFTD and DFT2 has been 
observed in two occasions (Kwon et al., 2018) but several infected 
individuals in this study (25% for both DFTD and DFT2) have been 
observed with multiple tumours, which may result in higher meta-
bolic demands and faster mortality rates as tumour load increases 
(Ruiz-Aravena et al., 2018; Wells et al., 2017). Multiple tumours be-
longing to the same clone within a single host could represent (a) 
separate infections from different donor tumours, (b) separate in-
fections from the same donor tumour or (c) within-host metastases 
from a single infection. Although in this study we were not able to 
resolve these alternatives, future work on genomic sequencing of 
tumours may provide the necessary data to determine the origin of 
multiple tumours within the same host and the resulting evolution-
ary processes between DFTD and DFT2.
There was a significant difference in the bodily location of tu-
mours between DFTD and DFT2, with a higher proportion of 
DFT2 tumours occurring more often on the body compared with 
DFTD. Although devil bite wounds have been recorded on the body 
(Hamede et al., 2013; Pemberton & Renouf, 1993), in the more 
than 15 years of tumour data on DFTD from multiple sites across 
Tasmania, non-facial tumours have been extremely rare, with only 
12 cases reported out of 1541 tumours from 574 individuals across 
multiple sites (Hamede R., unpublished data). Yet in this study, a third 
of the 40 DFT2 tumours were observed on the body. This suggests 
that transmission and establishment of DFT2 cells may be favour-
ing a different niche within the host. Alternatively, DFT2 tumours 
on the body could be the result of metastasis from facial tumours, 
which could be more likely to result in external metastasis than 
DFTD. However, four individuals with DFT2 had tumours on the 
body and not on the head, indicating that non-facial tumours can 
occur in the absence of facial tumours, whereas both individuals in 
this study with DFTD tumours on the body had facial tumours in 
addition to the body tumours. It is also possible that during the early 
evolution of DFTD non-facial tumours were more common, but due 
to a reduction in transmission efficiency, they became “dead ends” 
and tumours that readily grew in non-facial locations were selected 
against. Although non-facial tumours are more common in DFT2, 
more data are needed to establish if differences with DFTD are 
driven by within-host metastasis, mechanistic or selective processes.
DFT2 tumours are significantly more likely to infect male devils 
than female devils, differing from DFTD, which infects males and 
females equally, although females have been reported to have higher 
tolerance to DFTD infection (Ruiz-Aravena et al., 2018). It is pos-
sible that the infection dynamics differ between DFTD and DFT2; 
for instance, DFT2 transmission may be more likely to occur during 
male–male interactions than during male–female or female–female 
interactions. However, studies on biting injuries and contact pat-
terns have shown that most injuries occur between males and fe-
males during mating interactions (Hamede, Bashford, McCallum, & 
Jones, 2009; Hamede et al., 2013; Hamilton et al., 2019). A more 
plausible hypothesis is that females may have reduced susceptibility 
to DFT2. As DFT2 is a male cell line and carries a Y chromosome, 
in contrast to DFTD, which first arose from a female (Deakin et al., 
2012; Murchison et al., 2012; Pye, Pemberton, et al., 2016), it is plau-
sible that Y chromosome-derived antigens may facilitate an immune 
response in female devils challenged with DFT2. This hypothesis is 
supported by the observation of DFT2 Y chromosome deletion in a 
DFT2 tumour in a female host (Stammnitz et al., 2018). If loss of the 
Y chromosome is a selective advantage to DFT2, then it is expected 
that the frequency of DFT2 cases with Y chromosome loss should 
increase in the near future, accompanied by a more balanced host 
sex ratio. If females are indeed partially resistant to DFT2, then this 
would reduce the basic reproductive number R0 and could account 
for the apparent slower rate of spread and rate of increase in preva-
lence, in comparison with DFTD.
We found no difference in the age of infection between DFTD 
and DFT2. So far, there has been no evidence that adult age classes 
(>2 years) differ in their susceptibility to DFTD infection. Although 
sample sizes are low, most infections in this study occurred in 2 and 
3+ year-old devils in both DFTD and DFT2. Since devils typically 
reach sexual maturity at the age of 2 years and most biting occurs 
in sexually mature devils during mating interactions, it is expected 
that these age classes would be the most affected. Previous ep-
idemiological studies of DFTD have found higher prevalence of 
tumours in sexually matured adult individuals, with 1-year-old in-
dividuals rarely affected (Hamede et al., 2015; Lachish et al., 2007; 
Lazenby et al., 2018; McCallum et al., 2009). The low prevalence of 
DFTD and DFT2 in 1-year-old devils in this study is most likely due 
to limited mating interactions that are the primary source of bite 
wounds (Hamede et al., 2013; Hamilton et al., 2019). The higher 
prevalence of DFTD and DFT2 in sexually mature devils compared 
with young devils is therefore most likely driven by the higher ex-
posure to infectious bite wounds, although immune-driven differ-
ences in susceptibility to infection between age groups cannot be 
ruled out (Cheng et al., 2017; Ujvari, Hamede, et al., 2016).
Given that DFT2 was most likely detected early in its emer-
gence, or at least at low prevalence (Pye, Pemberton, et al., 2016), 
and all reported cases so far have been restricted to the d’Entre-
casteaux peninsula, we suggest that continual monitoring of the 
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disease to further evaluate its spread, transmission dynamics, 
population effects and evolutionary trajectory should be a pri-
ority. Considering that disease eradication strategies at a large 
scale are not logistically feasible and that Tasmanian devils may be 
prone to transmissible cancers in general (Storfer et al., 2018), we 
suggest that conservation efforts are focused on evaluating and 
maintaining the adaptive genetic diversity of devils in response to 
the DFTD and DFT2 epidemics and their potential evolutionary 
dynamics.
Competition and co-infection between DFTD and DFT2 may 
alter the current adaptive responses and evolutionary processes 
between devils and DFTD, resulting in changes in virulence and 
transmission dynamics in both cancers. There is increasing evi-
dence that oncogenic phenomena have an important role in driving 
ecological and evolutionary processes, from individuals to ecosys-
tems (Thomas et al., 2013, 2017; Vittecoq et al., 2018). The recent 
discovery of five transmissible cancers in marine bivalves (Metzger 
et al., 2016) suggests that malignant cell lines with the potential of 
becoming transmissible diseases are more common than previously 
thought. As Tasmanian devils have been affected by two transmis-
sible cancers over the last 20 years, it is also possible that these 
types of cancers have previously appeared and subsequently died 
out through the species’ evolutionary history (Ujvari, Gatenby, & 
Thomas, 2016). How these two transmissible cancers will interact 
is currently unknown, and it is possible that interactions between 
DFTD and DFT2 may alter acquired adaptive processes that have 
occurred in the devil-DFTD system for more than 20 years. These 
adaptations include changes in susceptibility to infection across 
tumour karyotypes (Hamede et al., 2015), devil immune expression 
profiles (Ujvari, Hamede, et al., 2016), the presence of antibodies 
associated with natural tumour regressions (Pye, Hamede, et al., 
2016), changes in allele frequencies of genes associated with im-
mune function in as little as four to six generations since exposure 
to DFTD (Epstein et al., 2016), as well as differences in tolerance 
and survival after infection (Margres et al., 2018; Ruiz-Aravena 
et al., 2018). Molecular studies have demonstrated that DFTD is 
subject to adaptability and evolutionary plasticity (Deakin et al., 
2012; Murchison et al., 2012; Pearse et al., 2012; Ujvari, Gatenby, 
et al., 2016; Ujvari et al., 2013) which may also affect epidemiol-
ogy and population effects. Continual monitoring of the DFT2 ep-
idemic and its interaction with DFTD in ecological timescales will 
be essential for understanding important concepts of cancer ecol-
ogy and evolution. This will allow evaluation of potential genetic 
management strategies and assessment of the conservation threat 
imposed by this newly evolved transmissible cancer.
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